Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
PolandEvaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
PolandStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
PolandStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
PolandEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
PolandEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
PolandA study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.
PolandA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
PolandA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
